Digital Diabetes Monitoring App Picks up $35 Million

Glooko, a digital disease management firm, has raised $35 million in an attempt to further develop its diabetes monitoring app. The app, which is named after the company, allows users to input unique information about their diets, habits, and glucose levels to help...

Medibio Announces Noninvasive PTSD Diagnostic

Medibio has announced study results indicating an 80% PTSD diagnosis rate of their objective mental health diagnostic. The company’s test is breaking into the market of noninvasive mental healthcare. Medibio partnered with Emory University to develop a classifier...

CBO Unveils New AHCA Score Before Senate Vote

The Congressional Budget Office has released a scoring of the American Healthcare Act after lawmakers unveiled Senate changes late last week. The scoring includes the number of Americans who will lose healthcare, along with a projected estimate for the total cost of...

Executive Order Said to Detail Pharmaceutical Industry Changes

A draft of an executive order detailing changes to the pharmaceutical industry has been obtained by journalists. In the document, President Trump outlines much of his earlier proposals to the industry in January. Namely, the document cites streamlined approval...

Motor Operated Suit Helps Stroke Victims Walk Again

ReWalk Robotics has released a softsuit exoskeleton designed for stroke victims. The suit uses motor operated knee joints and hips to enable survivors to stand and walk once again. The device, named Restore, works similarly to the company’s prior device, ReWalk (named...

Shire’s Adderall Copy Approved by FDA

Shire has announced the recent FDA approval for its Adderall iteration, Mydayis. The drug, which was denied approval by the FDA nearly a decade ago, was finally approved this week following the inspection of 16 clinical studies. Both adults and children were included...